Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas
Clinical trial NCT02388490 · COMPLETED
Trial details
- NCT number
- NCT02388490
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-25
- Primary completion
- 2019-04-02
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.